Main Article Content
Objectives: To determine the associated factors those predict the use of long-acting reversible contraception (LARC) among postpartum women at Srinagarind Hospital.
Materials and Methods: A cohort study of postpartum women was conducted at Srinagarind Hospital from May to October 2016. LARC methods were defined as progestogen-only injectable contraceptives, intrauterine devices, and contraceptive implants. The participants were interviewed during admission to the postpartum ward in order to ascertain baseline information, as well as information regarding their intention to use or not to use LARC. The participants were interviewed again after their six week postpartum visit about the contraceptive method they actually used. Data of participants who did not appear for their six-week postpartum visit were obtained by telephone interview within 6-12 weeks after delivery. Logistic regression analysis was applied to determine the factors associated with LARC use.
Results: The mean age of the participants was 28.4 ± 5.7 years. One hundred twenty-six out of a total of 312 participants (40.4%) reported using LARC. The methods of LARC used were depot medroxyprogesterone acetate (DMPA) (82.5%) and contraceptive implants (17.5%). Participants who were more likely to use LARC included those who had expressed their intention to use LARC during the first interview, current students, and women whose medical expenses were covered by universal coverage scheme.
Conclusion: Rate of LARC use in this study was approximately 40%. The most common method of LARC used was DMPA. Significant independent factors affecting the use of LARC were participants’ intentions, occupation, and type of health care coverage.
Keywords: contraceptive use, long-acting reversible contraception, postpartum women
2. Requejo JH, Bryce J, Barros AJ, Berman P, Bhutta Z, Chopra M, et al. Countdown to 2015 and beyond: fulfilling the health agenda for women and children. Lancet 2015;385:466-76
3. Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plan 2010;41:241-50.
4. Kost K, Landry DJ, Darroch JE. The effects of pregnancy planning status on birth outcomes and infant care. Fam Plan Perspect 1998;30:223-30.
5. Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA 2006; 295: 1809-23.
6. Zhu BP. Effect of interpregnancy interval on birth outcomes: findings from three recent US studies. Int J Gynaecol Obstet 2005;89:S25-33.
7. Chen I, Jhangri GS, Lacasse M, Kumar M, Chandra S. Relationship Between Interpregnancy Interval and Adverse Perinatal and Neonatal Outcomes in Northern Alberta. J Obstet Gynaecol Can 2015;37:598-605
8. Sriprasert I, Chaovisitsaree S, Sribanditmongkhol N, Sunthornlimsiri N, Kietpeerakool C. Unintended pregnancy and associated risk factors among young pregnant women. Int J Gynaecol Obstet 2015;128:228-31
9. Lanjakornsiripan W, Amnatbuddee S, Seejorn K, Werawatakul Y, Kleebkaow P, Komwilaisak R, Luanratanakorn S. Contraceptive practices and pregnancy intendedness among pregnant adolescents. Int J Womens Health 2015;7:315-20.
10. National Institute of Health and Care Excellent. Long-acting reversible contraception. Clinical guideline (CG 30). 2005 (last updated September 2014). Available at https://www.nice.org.uk/guidance/cg30
11. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol 2011;118:184-96.
12. Chaovisitsaree S, Noi-um S, Kietpeerakool C. Review of postpartum contraceptive practices at Chiang Mai University Hospital: implications for improving quality of service. Med Princ Pract 2012;21:145-9.
13. Adanikin AI, Onwudiegwu U, Loto OM. Influence of multiple antenatal counselling sessions on modern contraceptive uptake in Nigeria. Eur J Contracept Reprod Health Care 2013;18:381-7.
14. Society for Adolescent Health and Medicine. Improving Knowledge About, Access to, and Utilization of Long-Acting Reversible Contraception Among Adolescents and Young Adults. J Adolesc Health 2017;60:472-474